ResearchIn-Press PreviewCell biologyMetabolismOncology
Open Access |
10.1172/jci.insight.204554
1Department of Biomedical Engineering, Duke University, Durham, United States of America
2Department of Molecular Genetics & Microbiology, Duke University, Durham, United States of America
Find articles by Villares, E. in: PubMed | Google Scholar
1Department of Biomedical Engineering, Duke University, Durham, United States of America
2Department of Molecular Genetics & Microbiology, Duke University, Durham, United States of America
Find articles by Taber, N. in: PubMed | Google Scholar
1Department of Biomedical Engineering, Duke University, Durham, United States of America
2Department of Molecular Genetics & Microbiology, Duke University, Durham, United States of America
Find articles by Wu, S. in: PubMed | Google Scholar
1Department of Biomedical Engineering, Duke University, Durham, United States of America
2Department of Molecular Genetics & Microbiology, Duke University, Durham, United States of America
Find articles by Amelung, C. in: PubMed | Google Scholar
1Department of Biomedical Engineering, Duke University, Durham, United States of America
2Department of Molecular Genetics & Microbiology, Duke University, Durham, United States of America
Find articles by Wu, J. in: PubMed | Google Scholar
1Department of Biomedical Engineering, Duke University, Durham, United States of America
2Department of Molecular Genetics & Microbiology, Duke University, Durham, United States of America
Find articles by
Lin, C.
in:
PubMed
|
Google Scholar
|
1Department of Biomedical Engineering, Duke University, Durham, United States of America
2Department of Molecular Genetics & Microbiology, Duke University, Durham, United States of America
Find articles by
Chi, J.
in:
PubMed
|
Google Scholar
|
1Department of Biomedical Engineering, Duke University, Durham, United States of America
2Department of Molecular Genetics & Microbiology, Duke University, Durham, United States of America
Find articles by Gerecht, S. in: PubMed | Google Scholar
Published October 22, 2026 - More info
Matrix stiffness is a hallmark of aggressive solid tumors and strongly associated with therapeutic resistance and poor prognosis. This mechanical barrier represents a major unmet challenge in oncology, as current strategies rarely address how matrix mechanics themselves drive treatment resistance. Here, we identified ferroptosis, an iron-dependent form of cell death, as a potential long-sought vulnerability that can be exploited to eliminate mechanically resistant tumors. Using genetic and chemical approaches, we investigated how matrix stiffness sensitizes cancer cells to ferroptosis and whether this vulnerability can be therapeutically targeted. We found that cancer cells cultured on stiff matrices were more sensitive to ferroptosis than those on soft matrices, as evidenced by reduced cell viability and elevated lipid peroxidation. Furthermore, we found that matrix stiffness induced YAP activation, which upregulated its target gene SKP2, a key mediator required for the heightened ferroptosis sensitivity observed under stiff conditions. Finally, using an injectable hydrogel system, we demonstrated that stiffened tumors were resistant to chemotherapy but remained highly susceptible to ferroptosis induction, resulting in markedly reduced tumor volume and weight. Our findings established ferroptosis as a stiffness-dependent vulnerability mediated by a YAP-SKP2 signaling axis, revealing a mechanotransductive pathway that may be leveraged to target treatment-refractory tumors.